MedTrace Logo

Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation

NCT01259622 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2011-05-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of a single intravenous infusion of K201 compared to placebo in a dose escalating manner on conversion to sinus rhythm, reduction of subject's symptom score, and safety.

Conditions

Interventions

DRUG

saline

intravenous infusion

DRUG

K201

intravenous infusion

Sponsors & Collaborators

  • Sequel Pharmaceuticals, Inc

    lead INDUSTRY

Principal Investigators

  • Paul Chamberlin, MD · Sequel Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-10-31
Completion
2011-12-31

Countries

  • Denmark
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01259622 on ClinicalTrials.gov